您的位置: 首页 > 农业专利 > 详情页

Antibodies to epidermal growth factor receptor 3 (HER3)
专利权人:
Novartis AG
发明人:
ELIS, Winfried,ETTENBERG, Seth,GARNER, Andrew Paul,HAUBST, Nicole,HUANG, Xizhong,KUNZ, Christian Carsten Silvester,REISINGER SPRAGUE, Elizabeth Anne,SHENG, Qing
申请号:
ES12813984
公开号:
ES2758433T3
申请日:
2012.12.04
申请国别(地区):
ES
年份:
2020
代理人:
摘要:
This invention relates to antibodies or fragments thereof which interact with HER family of receptors, e.g., HER3 receptor. In particular, it relates to antibodies or fragments thereof that recognize a conformational epitope of HER3 receptor comprising residues from both domains 2 and 4 resulting in inhibition of both ligand-dependent and ligand-independent signal transduction; and allow ligand binding (e.g., neuregulin), whilst preventing ligand-induced activation of signal transduction. These antibodies or fragments can be used to treat a number of diseases or disorders characterized by increased levels of HER3 expression (e.g., esophageal cancer). These antibodies or fragments can be used to treat a number of diseases or disorders characterized by the antibodys or fragments ability to decrease tissue weight (e.g., prostate or uterine weights) or to induce atrophy of tissue (e.g., atrophy of male breast).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充